Mirxes Holding Company Limited (HKG:2629)

Hong Kong · Delayed Price · Currency is HKD

12.41

-3.15 (-20.24%)

Mar 31, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Early Detection and Precision Multi-Omics	17.65M	17.48M	10.27M
Early Detection and Precision Multi-Omics Growth	0.97%	70.22%	-
Infectious Diseases	2.63M	6.70M	7.49M
Infectious Diseases Growth	-60.76%	-10.50%	-
Total	20.28M	24.19M	17.76M
Total Growth	-16.14%	36.18%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Singapore	12.12M	14.93M	6.79M
Singapore Growth	-18.80%	119.97%	-
PRC	6.93M	5.80M	3.51M
PRC Growth	19.54%	65.35%	-
Indonesia	4.70K	911.07K	2.48M
Indonesia Growth	-99.48%	-63.25%	-
Others	1.13M	987.26K	245.87K
Others Growth	14.93%	301.54%	-
Philippines	85.67K	1.49M	2.54M
Philippines Growth	-94.23%	-41.57%	-
Switzerland	-	70.72K	1.02M
Switzerland Growth	-	-93.03%	-
Vietnam	-	-	1.18M
Total	20.28M	24.19M	17.76M
Total Growth	-16.14%	36.18%	-